Pharmacy emergency uptravi 200/400 MG

Ended Awarded

Contract number
36C26020F0548
Awardee
Awarding agency
Obligated
$36,437

Award facts

Contract value 100% obligated
$36,436.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Modification $42,505
Funding Only Action P00001 -$6,068

About this award

This federal contract award was made by the Veterans Integrated Service Network 20 (VISN 20), a division of the Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc. The $36,436.95 Firm Fixed Price contract is a call against Actelion's existing $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The award is for the delivery of UPTRAVI, a medication used to treat pulmonary arterial hypertension, which is a critical treatment for veterans and other eligible federal beneficiaries. Actelion is a large pharmaceutical manufacturer that specializes in rare disease therapies and does not typically utilize small business set-asides. This contract award is associated with Actelion's broader $60 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for pulmonary arterial hypertension drugs, as well as a newer $83.5 million single-award BPA established in 2024 for a one-year period.

Quick answers

Who was awarded contract 36C26020F0548?

36C26020F0548 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 21, 2020.

How much is contract 36C26020F0548 worth?

The government has obligated $36,437 on 36C26020F0548.

Is contract 36C26020F0548 an order under another contract?

Yes. 36C26020F0548 is a BPA call under 36F79719D0142-36E79719A0019, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26020F0548 competed?

The extent of competition for 36C26020F0548 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award